文献速递胸部肿瘤乳腺癌消化系统肿瘤

2022年东南亚癌症发病与死亡估计:一项比较分析

Cancer incidence and mortality estimates in 2022 in southeast Asia: a comparative analysis.
PubMed 文献 · Lancet Oncol · 2025-02-27

研究基于GLOBOCAN 2022数据,提取东南亚11国及中国、印度、日本、巴基斯坦、韩国、美国的癌症发病与死亡估计值,计算年龄标化发病率和死亡率,并推算至2050年。结果显示女性以乳腺癌为主,男性以肺癌为主,部分国家感染相关癌症(肝癌和宫颈癌)常见。

要点

  • 2022年东南亚11国癌症新发1,146,810例,死亡716,116例。
  • 女性乳腺癌在所有国家均为最常见癌症,男性肺癌在菲律宾、马来西亚、缅甸、印度尼西亚最常见。

核心结论

  • 东南亚当前癌症发病和死亡模式主要由女性乳腺癌和男性肺癌驱动,但感染相关癌症(肝癌和宫颈癌)在某些国家常见。
  • 必须加强区域合作以改善东南亚的癌症预防、诊断、治疗和研究。

研究设计与样本

  • 从国际癌症研究机构开发的GLOBOCAN 2022数据库提取东南亚11国所有癌症合计及主要癌症的新发和死亡例数。
  • 同时提取中国、印度、日本、巴基斯坦、韩国和美国的估计值作为比较。
  • 估计每10万人年的年龄标化发病率(ASIR)和年龄标化死亡率(ASMR),并通过将2022年ASIR和ASMR乘以2050年预期人口推算至2050年。
  • 未收集种族或民族数据。
  • 数据提取于2024年12月5日。

主要发现

  • 2022年东南亚11国所有癌症合计新发1,146,810例,其中男性545,725例(47.6%),女性601,085例(52.4%)。
  • 同期死亡716,116例,其中男性385,430例(53.8%),女性330,686例(46.2%)。
  • 男性和女性总癌症ASIR最高均为新加坡(男性235.89/10万,女性231.01/10万),男性ASMR最高为老挝(132.91/10万),女性ASMR最高为文莱(104.20/10万)。
  • 女性乳腺癌在所有国家均为最常见癌症(ASIR最高为新加坡72.61/10万和菲律宾60.34/10万),在菲律宾、马来西亚、新加坡、越南、印度尼西亚和东帝汶为女性癌症死亡最常见原因(ASMR分别为21.47、19.30、17.82、14.67、14.35、10.24/10万)。
  • 男性肺癌在菲律宾、马来西亚、缅甸和印度尼西亚为最常诊断癌症(ASIR分别为37.66、23.23、21.59、21.30/10万),在菲律宾、新加坡、文莱、马来西亚、缅甸、印度尼西亚和东帝汶为癌症死亡主要原因(ASMR分别为33.59、31.94、23.84、20.42、19.91、18.96、12.95/10万)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cancer is a leading cause of morbidity and mortality in southeast Asia. We aimed to present and interpret cancer incidence and mortality statistics in the 11 constituent countries of Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, Timor-Leste, and Viet Nam to inform research priorities, health services, and cancer policy. METHODS: The number of new incident cases and deaths for all cancers combined and for leading cancers were extracted from the GLOBOCAN 2022 database developed by the International Agency for Research on Cancer for the 11 countries in southeast Asia. For comparison, we extracted estimates from China, India, Japan, Pakistan, South Korea, and the USA. We estimated age-standardised incidence rates (ASIRs) and age-standardised mortality rates (ASMRs) per 100 000 person-years; projections to 2050 were also estimated by multiplying ASIR and ASMR estimates for 2022 by the expected population for 2050. Data on race or ethnicity were not collected. FINDINGS: Data were extracted on Dec 5, 2024. For the 11 countries in southeast Asia for all cancers combined, 545 725 (47·6%) of a total of 1 146 810 incident cases were estimated in men and 601 085 (52·4%) incident cases were estimated in women in 2022. In the same period, 385 430 (53·8%) of a total of 716 116 deaths were estimated in men and 330 686 (46·2%) deaths were estimated in women. The total cancer ASIR in men and women was highest in Singapore (235·89 per 100 000 and 231·01 per 100 000 respectively), while the corresponding ASMR was greatest in Laos for men (132·91 per 100 000) and Brunei for women (104·20 per 100 000). Breast cancer was the most common cancer among women in all countries (highest ASIRs in Singapore [72·61 per 100 000] and the Philippines [60·34 per 100 000]), and the most common cause of cancer mortality among women in the Philippines (ASMR 21·47 per 100 000), Malaysia (19·30 per 100 000), Singapore (17·82 per 100 000), Viet Nam (14·67 per 100 000), Indonesia (14·35 per 100 000), and Timor-Leste (10·24 per 100 000). Among men, lung cancer was the most frequently diagnosed cancer in the Philippines (ASIR 37·66 per 100 000), Malaysia (23·23 per 100 000), Myanmar (21·59 per 100 000), and Indonesia (21·30 per 100 000), and the leading cause of death due to cancer in the Philippines (ASMR 33·59 per 100 000), Singapore (31·94 per 100 000), Brunei (23·84 per 100 000), Malaysia (20·42 per 100 000), Myanmar (19·91 per 100 000), Indonesia (18·96 per 100 000), and Timor-Leste (12·95 per 100 000). Liver cancer contributed the greatest incidence and mortality in men in Cambodia, Laos, Viet Nam, and Thailand, and was also the leading cause of death due to cancer among women in Laos (ASMR 13·49 per 100 000), Cambodia (13·34 per 100 000), and Thailand (12·14 per 100 000). Cervical cancer was the leading cause of death due to cancer in women in Myanmar (ASMR 13·37 per 100 000); colorectal cancer was the most common cancer in men in Singapore (ASIR 39·41 per 100 00) and Brunei (37·70 per 100 000). By 2050, 2·03 million new cases of cancer are anticipated in southeast Asia annually, an 89·2% increase in men and a 65·6% increase in women, relative to 2022. INTERPRETATION: The current patterns of cancer incidence and mortality in southeast Asia are primarily driven by breast cancer in women and lung cancer in men, but infection-related cancers (liver and cervix) are common in some countries. Regional collaborations must be strengthened to improve cancer prevention, diagnosis, care, and research in southeast Asia. FUNDING: National Cancer Institute and the Prostate Cancer Foundation.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Dee EC, Laversanne M, Bhoo-Pathy N, et al. Cancer incidence and mortality estimates in 2022 in southeast Asia: a comparative analysis. Lancet Oncol. 2025. PMID: 40024257. doi:10.1016/S1470-2045(25)00017-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。